Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing TRUS-Guided Prostrate Biopsy With or Without MR Fusion For Prostrate Tissue Classification Algorithm Development

NCT02928640 is registered in ClinicalTrials.gov with Precision Biopsy, Inc. as lead sponsor.

NCT NCT02928640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing TRUS-Guided Prostrate Biopsy With or Without MR Fusion For Prostrate Tissue Classification Algorithm Development
Lead sponsor
Precision Biopsy, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cellular diagnosis, prostate cancer